Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:16 pm Sale |
2024-12-31 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Schonfeld Strategic Advisors LLC | 1,314,915 2.820% |
-457,800 (-25.82%) |
Filing History |
| 2025-02-07 4:10 pm Sale |
2024-12-31 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
CVI Investments, Inc. | 2,446,376 4.900% |
-886,956 (-26.61%) |
Filing History |
| 2025-01-31 9:31 pm Purchase |
2024-12-18 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Parag Saxena | 6,268,906 12.400% |
17,300 (+0.28%) |
Filing History |
| 2024-12-23 11:30 am Purchase |
2024-12-16 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
CVI Investments, Inc. | 3,333,332 7.200% |
3,333,332 (New Position) |
Filing History |
| 2024-12-20 4:30 pm Purchase |
2024-12-18 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Bhat Laxminarayan | 3,198,242 6.800% |
304,328 (+10.52%) |
Filing History |
| 2024-11-14 5:16 pm Purchase |
2024-09-30 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Armistice Capital, LLC | 3,357,953 9.990% |
1,593,953 (+90.36%) |
Filing History |
| 2024-11-14 4:15 pm Purchase |
2024-09-30 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Schonfeld Strategic Advisors LLC | 1,772,715 5.300% |
1,772,715 (New Position) |
Filing History |
| 2024-08-23 4:07 pm Purchase |
2024-08-22 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Parag Saxena | 6,251,606 16.900% |
6,251,606 (New Position) |
Filing History |
| 2024-08-23 4:06 pm Purchase |
2024-08-22 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Bhat Laxminarayan | 2,893,914 8.600% |
8,236 (+0.29%) |
Filing History |
| 2024-08-14 4:07 pm Purchase |
2024-08-06 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Integrated Core Strategies (US) LLC | 1,563,595 5.200% |
1,563,595 (New Position) |
Filing History |
| 2024-05-31 9:30 pm Sale |
2024-05-29 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH |
VEDANTA PARTNERS LLC | 6,251,606 18.500% |
-152,811 (-2.39%) |
Filing History |
| 2024-02-16 4:32 pm Purchase |
2023-11-20 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Bhat Laxminarayan | 2,885,678 10.200% |
74,133 (+2.64%) |
Filing History |
| 2024-02-14 4:00 pm Purchase |
2023-12-31 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
TANG CAPITAL PARTNERS LP | 3,098,615 9.990% |
832,386 (+36.73%) |
Filing History |
| 2024-02-14 3:52 pm Purchase |
2023-12-31 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Armistice Capital, LLC | 1,764,000 6.320% |
1,764,000 (New Position) |
Filing History |
| 2023-11-30 4:49 pm Purchase |
2023-11-20 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH |
VEDANTA PARTNERS LLC | 6,404,417 19.900% |
339,243 (+5.59%) |
Filing History |
| 2023-05-05 4:30 pm Purchase |
2023-04-25 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Bhat Laxminarayan | 2,811,545 13.500% |
332,689 (+13.42%) |
Filing History |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
TANG CAPITAL PARTNERS LP | 2,266,229 9.990% |
916,049 (+67.85%) |
Filing History |
| 2022-09-12 4:35 pm Purchase |
2022-09-08 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH |
VEDANTA PARTNERS LLC | 6,065,174 19.900% |
2,766,798 (+83.88%) |
Filing History |
| 2022-01-05 12:35 pm Sale |
2021-12-31 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
SABBY MANAGEMENT LLC | 0 0.000% |
-904,710 (Position Closed) |
Filing History |
| 2021-06-11 6:07 pm Purchase |
2021-06-01 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Nayar Rahul | 515,651 3.000% |
515,651 (New Position) |
Filing History |